Recardio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.recardio.eu
Kancera Advances Cardiovascular Drug Pipeline with Recardio Partnership and FDA Engagement
Kancera AB has partnered with US biotech Recardio Inc. to create a cardiovascular disease-focused specialty care company, with Recardio licensing candidate drugs KAND567 and KAND145.
© Copyright 2025. All Rights Reserved by MedPath